NCT05365412 Clinicopathological Characteristics of Colon Cancer in Young Age
| NCT ID | NCT05365412 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seoul National University Bundang Hospital |
| Condition | Colo-rectal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,400 participants |
| Start Date | 2019-01-01 |
| Primary Completion | 2026-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,400 participants in total. It began in 2019-01-01 with a primary completion date of 2026-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A Study on the Characteristics of Colorectal Cancer by Age and sex.
Eligibility Criteria
Inclusion Criteria: * Patients treated after being diagnosed with colorectal cancer Exclusion Criteria: * Patients under age of 18 years, or patients who cannot choose whether to participate or not * Patients who refuse to participate in the study
Contact & Investigator
Nayoung Kim, MD, PhD
STUDY CHAIR
Seoul National University Bundang Hospital
Frequently Asked Questions
Who can join the NCT05365412 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colo-rectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05365412 currently recruiting?
Yes, NCT05365412 is actively recruiting participants. Contact the research team at nakim49@snu.ac.kr for enrollment information.
Where is the NCT05365412 trial being conducted?
This trial is being conducted at Seongnam-si, South Korea.
Who is sponsoring the NCT05365412 clinical trial?
NCT05365412 is sponsored by Seoul National University Bundang Hospital. The principal investigator is Nayoung Kim, MD, PhD at Seoul National University Bundang Hospital. The trial plans to enroll 1,400 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.